Infectious Disease Special Edition

Home
United States
New York, NY
Infectious Disease Special Edition

Infectious Disease Special Edition (IDSE), is a comprehensive resource on treatments, procedures and infection prevention for healthcare providers.

Infectious Disease Special Edition (IDSE), is a bi-annual magazine that features features about infectious diseases and reviews written by ID experts. The magazine is read by infectious disease specialists, primary care physicians, epidemiologists, pharmacists, nurses and others involved in the treatment of infectious diseases. Each issue offers a collection of review articles written by leading clinicians and scientists. These reviews present topical, accurate, and comprehensive information on topics covering a wide range of patient populations and therapeutic areas. They are designed to serve as a “one-stop” resource for clinicians and researchers. IDSE takes into account the time constraints of its readers, and offers a compendium of clinical reference tools that are easy to read, with useful and clinical relevant drug tables and treatment algorithms designed to assist readers in their clinical practice.

12/01/2017

World AIDS Day

Remember to read the full print edition of Infectious Disease Special Edition. Not a subscriber? Click here for more information. Copyright © 2017 McMahon Publishing unless otherwise noted.Infectious Disease Special Edition and www.idse.net are part of McMahon Publishing. All rights reserved. Repro...

12/01/2017

Today is World AIDS Day. The theme is "Everybody counts" where everyone has access to safe, effective, quality and affordable HIV services, medicines, diagnostics other health commodities for all people who need them. Universal health coverage means that all people receive the health services they need without experiencing financial hardship, including access to the full range of HIV services.

HIV-Positive Patients Not Getting Cardiovascular Care

11/29/2017

Testing for HIV

HIV-Positive Patients Not Getting Cardiovascular Care

11/28/2017

CDC: Too many missed opportunities to get people tested for HIV. http://www.idse.net/HIV-AIDS--STIs/Article/11-17/HIV-Testing-in-America-Delays-Missed-Opportunities/45339

11/27/2017

Those with HIV at higher risk for CVD, but unlikely to receive statins. http://www.idse.net/HIVAIDS-STIs/article/11-17/People-With-HIV-Less-Likely-to-Receive-Statins/45329

11/22/2017

FDA approves Juluca by ViiV Healthcare, the first complete treatment regimen containing only two drugs for the maintenance treatment of HIV infection.
http://www.idse.net/HIV-AIDS--STIs/Article/11-17/FDA-Approves-Juluca-First-2-Drug-Regimen-for-HIV/45306

This chart from the folks at @SanFranciscoOnlineMSN might come in handy for World Antibiotic Awareness Week. http://idse...

11/15/2017

The Rise of Antibiotic Resistance

This chart from the folks at @SanFranciscoOnlineMSN might come in handy for World Antibiotic Awareness Week. http://idse.net/Bacterial-Infections/Article/11-17/The-Rise-of-Antibiotic-Resistance/45255

This week is World Antibiotic Awareness Week. The rise of antibiotic resistance is leading to untreatable infections and a threat to global health, food security and drug development.

11/09/2017

FDA Approves Prevymis CMV Prophylaxis

11/08/2017

GBS Major Cause of Infant Death and Stillbirths

11/01/2017

10/26/2017

ACIP Recommends Shingrix for Adults 50 and Older

10/26/2017

CDC’s ACIP Recommends Adding Shingrix to the Adult Vaccination Schedule

ACIP recommends #Shingrix to the adult vaccination schedule for those 50 and older. http://www.idse.net/Immunology--Vaccination/Article/10-17/CDC-s-ACIP-Recommends-Adding-Shingrix-to-the-Adult-Vaccination-Schedule-/45062

The committee voted to include Shingrix (GlaxoSmithKline) in the adult vaccination recommendations for to prevent shingles in immunocompetent adults 50 and older.

10/25/2017

9 Tools for a Better Antibiogram

10/18/2017

C. difficile Infection Management

10/16/2017

U.S. Food and Drug Administration issues warning about compounded ocular antibiotic causing blindness after common procedure. http://www.idse.net/Bacterial-Infections/Article/10-17/FDA-Compounded-Ocular-Antibiotic-May-Cause-Blindness/44931

10/13/2017

Infectious Diseases Society of America

IDSA and HIVMA strongly urge the Trump administration to send emergency funding to avert public health crises in Puerto Rico and the U.S. Virgin Islands. We need to act quickly to fight infectious diseases in these areas. Full statement: http://bit.ly/2wO5UcI

10/13/2017

Infectious Diseases and Vaccines

Herpes Vaccine Update: An Interview With Penn's Dr. Harvey Friedman.

10/13/2017

NHAS: Stopping HIV in Its Tracks

90-90-90 could save many lives. http://www.idse.net/HIV-AIDS--STIs/Article/10-17/NHAS-Stopping-HIV-in-Its-Tracks/44928

The goal 90-90-90: Diagnosing 90% of all HIV-infected people, prescribing ART to 90% of those diagnoses and reaching virologic suppression among 90% of those receiving ART.

Winning the ‘Antibiotic Game’ With Pneumonia

10/13/2017

Antimicrobial Efficacy Ap

Winning the ‘Antibiotic Game’ With Pneumonia

10/11/2017

Experimental HIV Drugs Look Positive

10/11/2017

Single-Tablet Combo as Effective as Current HIV Treatment

Experimental HIV drug looks promising. http://www.specialtypharmacycontinuum.com/Web-Only/Article/10-17/Single-Tablet-Combo-as-Effective-as-Current-HIV-Treatment/44853

If approved in the U.S., D/C/F/TAF would be the only complete regimen that could deliver the potential adherence benefit of a once-daily single-tablet regimen.

10/06/2017

IDWeek: Preventing Pandemic Flu

Remember to read the full print edition of Infectious Disease Special Edition. Not a subscriber? Click here for more information. Copyright © 2017 McMahon Publishing unless otherwise noted.Infectious Disease Special Edition and www.idse.net/ are part of McMahon Publishing. All rights reserved. Repro...

10/06/2017

Getting Kids to Wash Their Hands? Make It Fun and Educational

Make hand washing fun and educational http://www.idse.net/Pediatric-Infections/Article/10-17/Getting-Kids-to-Wash-Their-Hands-Make-It-Fun-and-Educational/44825

In the 30 days after the experiment began, the teachers reported they observed a 68% to 100% improvement in hand-washing behavior among the five classes.

10/05/2017

CDC: Novel H7N9 Flu Virus, ‘Biggest Concern’ for Pandemic Capacity

IDWeek A novel avian flu virus causes concern about its ability to become a deadly pandemic.
http://www.idse.net/Respiratory-Tract-Infections--Influenza/Article/10-17/CDC-Novel-H7N9-Flu-Virus-Biggest-Concern-for-Pandemic-Capacity/44817

A novel avian influenza virus that is becoming more virulent and resistant, is being watched carefully because of fears of a pandemic.

09/29/2017

Improving Antimicrobial Stewardship with Faster Susceptibility Results: Use of the Accelerate™ PhenoTest BC Kit

Read our new monograph on rapid testing and stewardship. http://www.idse.net/Monographs-and-Whitepapers/Article/09-17/Improving-Antimicrobial-Stewardship-with-Faster-Susceptibility-Results-em-Use-of-the-Accelerate-PhenoTest-BC-Kit-em-/44717

This monograph describes clinical experience using the Accelerate Pheno™ system in shortening time to optimal antibiotic therapy with standardized antimicrobial stewardship intervention practices.

@CDC reports unhealthy trend: Record number of STDs. http://www.idse.net/HIV-AIDS--STIs/Article/09-17/At-More-than-2-Mil...

09/27/2017

At More than 2 Million, CDC Reports Record High Rates of STDs in U.S.

@CDC reports unhealthy trend: Record number of STDs. http://www.idse.net/HIV-AIDS--STIs/Article/09-17/At-More-than-2-Million-CDC-Reports-Record-High-Rates-of-STDs-in-U-S-/44706

There were 1.6 million new cases of chlamydia, 470,000 cases of gonorrhea and almost 28,000 cases of primary and secondary syphilis reported in 2016.

09/27/2017

Ticks Are Tougher, Nastier Than You Thought

University of Cincinnati researchers finding out just how nasty ticks area
http://www.idse.net/From-Zoo-to-You/Article/09-17/Ticks-Are-Tougher-Nastier-Than-You-Thought/44694

Tick species appear to be expanding their range, which means the diseases they carry could be an emerging concern to new areas.

09/27/2017

Infectious Disease Special Edition's cover photo

09/27/2017

Selzentry being studied for PrEP. http://www.idse.net/Bacterial-Infections/Article/09-17/Positive-Results-for-Selzentry-as-PrEP-Candidate-in-Women/44651

09/27/2017

Fake antibiotics among the drugs sold by rogue pharmacies, FDA says. http://www.idse.net/Policy--Public-Health/Article/10-17/FDA-Takes-Action-Against-Rogue-Online-Pharmacies/44689

09/27/2017

Infectious Disease Special Edition

09/21/2017

Object reference not set to an instance of an object.

http://www.idse.net//HospitalAcquired-Infection/article/09-17/Pressure-Injury-Diagnosis-Is-Inconsistent-May-Be-Inaccurate/44652

03/06/2013

InfectiousDiseaseSE (IDSE_Online) on Twitter

The latest from InfectiousDiseaseSE (@IDSE_Online). Infectious Disease Special Edition (IDSE), is a comprehensive resource on treatments, procedures and infection prevention for healthcare providers. New York, NY

From a Phase II EMERGE trial, a new interferon, peginterferon lambda-1a, may help improve treatment for patients with he...

03/06/2013

Souped-Up IFN Could Improve HCV Treatment

From a Phase II EMERGE trial, a new interferon, peginterferon lambda-1a, may help improve treatment for patients with hepatitis C (HCV). IDSE spoke with Andrew J. Muir, MD, MHS, the clinical director of hepatology at Duke University Medical Center, in Durham, N.C. about the novel interferon treatment.

“Improved tolerability, together with faster time to virologic response, supports the further assessment of lambda-based direct-acting antiviral combination regimens in patients chronically infected with HCV genotypes 1 or 4,” said Andrew J. Muir, MD, MHS, clinical director of hepatology at Duke Uni...

Interferon (IFN)-free therapies are on the horizon for patients with Hepatitis C (HCV) infection. In this article we sha...

03/01/2013

Potential IFN-Free Regimens For HCV

Interferon (IFN)-free therapies are on the horizon for patients with Hepatitis C (HCV) infection. In this article we share highlights from some of the trials of IFN-free therapies presented at the American Association for the Study of Liver Diseases (AASLD) meeting.

“We can see a light at the end of the tunnel,” said Guadalupe Garcia-Tsao, MD, professor of medicine at Yale University, New Haven, Conn., and chief of the section of digestive diseases at the Connecticut Veterans Affairs Healthcare System, West Haven, referring to a future that includes IFN-free re...

Address

New York, NY

Telephone

212-957-5300

Website

www.IDSE.net

Alerts

Be the first to know and let us send you an email when Infectious Disease Special Edition posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.